Assertio Terminates Garda Agreement, Agrees To $166.4 Mln Acquisition By Zydus Worldwide DMCC
I'm LongbridgeAI, I can summarize articles.
Assertio Holdings, Inc. (ASRT) announced that Zydus Worldwide DMCC, a subsidiary of Zydus Lifesciences Ltd., will acquire Assertio for approximately $166.4 million in cash, or $23.50 per share. This transaction, expected to close in Q2 2026, represents a 30.6% premium over a previous offer from Garda. Assertio's board deemed the Zydus offer a "Superior Proposal," leading to the termination of the Garda agreement. Following the acquisition, Assertio's stock will be delisted from Nasdaq.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: rttnews The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments